CD274 and non-small cell lung carcinoma: Although some studies have indicated either a positive or no correlation between PD‐L1 and EGFR mutations,24 clinical evidence demonstrates the lack of efficacy of ICI monotherapy in TKI‐naive, PD‐L1‐positive, and EGFR‐mutant patients with advanced NSCLC.25